Dublin, Feb. 07, 2017 -- Research and Markets has announced the addition of the "Aortic Aneurysm Repair Devices Global Market - Forecast to 2023" report to their offering.
An aneurysm develops due to the weakening of blood vessel which results in a balloon-like dilation. Aneurysms can occur in any artery, it happens most often in the abdominal aorta, an essential blood vessel that supplies blood to legs. Most aortic aneurysms occur in the section of the aorta that passes through the abdomen and are referred as abdominal aortic aneurysms, sometimes in the chest referred as thoracic aortic aneurysms.
Normally the diameter of the aorta in the abdomen is about 2 cm but in the case of an abdominal aortic aneurysm, the diameter increases to 3 cm or even more. Once an aortic aneurysm develops gradually it tends to become larger and the speed at which it becomes larger varies from person to person. Generally, aneurysm tends to become larger by about 10% per year. This condition rarely happens in the age group below 60 years. The wall of the aorta normally has layers of elastin, collagen and smooth muscle tissue.
As people grow older aorta loses its normal strength and elasticity due to changes in the elastin, collagen and smooth muscle tissues. Genetic makeup also plays a major part in the development of aortic aneurysms. The condition can be treated by either open surgery or by EVAR procedure. EVAR is a minimally-invasive newer technique which employs stent grafts and other components like catheter, guide wires and other devices to repair an aortic aneurysm and has become a popular option in recent years.
Companies Mentioned:
- Abiomed (U.S.)
- B.Braun GmbH (Germany)
- BiFlow medical (Israel)
- Bolton Medical (U.S.)
- Boston Scientific corporation (U.S.)
- Braile Biomedica (Brazil)
- Cardiatis (Belgium)
- Cardinal Health, Inc. (U.S.)
- Cook Medical, Inc. (U.S.)
- Cytograft Tissue Engineering, Inc. (U.S.)
- Endologix, Inc. (U.S.)
- Endospan (Israel)
- Fuji Systems Corporation (Japan)
- Getinge Groups (Maquet) (Sweden)
- GRIKIN Advanced Materials (China)
- (10+ Others)
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
4 Aortic Aneurysm Repair Devices Global Market, by Site
5 Aortic Aneurysm Repair Devices Global Market, by Product
6 Aortic Aneurysm Global Market, by Repair Type
7 Aortic Aneurysm Repair Devices Global Market, by Region
8 Company Developments
9 Major Player Profiles
For more information about this report visit http://www.researchandmarkets.com/research/mxs3p3/aortic_aneurysm
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Procedures , Surgical Devices


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



